Immune Checkpoint Inhibitor-Related Hypophysitis: A Call for Vigilance

Immune Checkpoint Inhibitor-Related Hypophysitis: A Call for Vigilance

Saved in:

Bibliographic Details
Main Author:	Ju Hee Lee
Format:	Article
Language:	English
Published:	Korean Endocrine Society 2025-06-01
Series:	Endocrinology and Metabolism
Online Access:	http://www.e-enm.org/upload/pdf/enm-2025-2477.pdf
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Analysis of the clinical characteristics of immune checkpoint inhibitor-related hypophysitis
by: Zhixiao WANG, et al.
Published: (2025-08-01)

Immune Checkpoint Inhibitor–Mediated Aseptic Meningitis and Hypophysitis
by: Pavel Bleik, et al.
Published: (2025-01-01)

Hypophysitis induced by immune checkpoint inhibitors in a Scottish melanoma population
by: Khor Zhong Wei, et al.
Published: (2019-03-01)

Pituitary enlargement and hypopituitarism in patient with lung cancer treated with immune checkpoint inhibitors: Metastasis or hypophysitis? Role of imaging
by: Pier Paolo Arcuri, MD, et al.
Published: (2025-04-01)

High-dose glucocorticoid treatment vs. glucocorticoid replacement in immune checkpoint inhibitor associated hypophysitis (CORTICI): an open, randomised controlled trial
by: Verena Theiler-Schwetz, et al.
Published: (2025-12-01)

The resurgence of diphtheria: A call for vigilance
by: Diganta Banerjee, et al.
Published: (2025-07-01)

Letter to the Editor: ‘High-dose glucocorticoid treatment vs. glucocorticoid replacement in immune checkpoint inhibitor-associated hypophysitis (CORTICI): an open, randomized controlled trial’
by: Mohammad Aitzaz Hassan, et al.
Published: (2025-12-01)

Leprosy with comorbidities: A call for strengthening vigilance
by: Senthilkumar Ramasamy, et al.
Published: (2025-04-01)

Sintilimab for the treatment of lung adenocarcinoma-induced immune-related hypophysitis: a case report
by: Ming-xing Wang, et al.
Published: (2025-01-01)

Plagiarism in the Age of Artificial Intelligence: A Call for Ethical Vigilance
by: Krupal Joshi, et al.
Published: (2025-01-01)

Campylobacteriosis following immunosuppression for immune checkpoint inhibitor-related toxicity
by: Karla A Lee, et al.
Published: (2020-10-01)

Immune-related hepatitis and hypophysitis are associated with superior survival in melanoma patients treated with combined ipilimumab and nivolumab
by: Hifaa Al Remawi, et al.
Published: (2025-12-01)

Negative Immune Checkpoint Inhibitors
by: Magda Drewniak-Świtalska, et al.
Published: (2025-05-01)

Immune Checkpoint Inhibitor-Related Sjögren’s Syndrome: An Ocular Immune-Related Adverse Event
by: Hideki Fukuoka, et al.
Published: (2025-05-01)

Immune checkpoint inhibitor-related myocarditis in patients with lung cancer
by: Wenli Cao, et al.
Published: (2025-04-01)

Germline prediction of immune checkpoint inhibitor discontinuation for immune-related adverse events
by: Min Li, et al.
Published: (2025-03-01)

Chronic immune checkpoint inhibitor pneumonitis
by: Julie R Brahmer, et al.
Published: (2020-05-01)

Consensus disease definitions for ophthalmic immune-related adverse events of immune checkpoint inhibitors
by: Lauren A Dalvin, et al.
Published: (2025-04-01)

Clinical features of immune checkpoint inhibitor-related pneumonitis in older patients with lung cancer receiving immune checkpoint inhibitors-based therapy: a retrospective study
by: Jiafan Liu, et al.
Published: (2025-04-01)

Adverse reactions of immune checkpoint inhibitors
by: E. R. Zagidullina, et al.
Published: (2025-06-01)

Application of Immune Checkpoint Inhibitors in Cancer
by: Zhijun Chen, et al.
Published: (2025-08-01)

Hepatotoxicity induced by immune checkpoint inhibitors
by: Flaviu Muresan, et al.
Published: (2024-10-01)

Pouchitis After Immune Checkpoint Inhibitors
by: Gabriel Sperling, et al.
Published: (2023-08-01)

Immune Checkpoint Inhibitors in the Treatment of Lymphomas
by: KV Lepik
Published: (2018-10-01)

Histologic and immune characterization of cutaneous immune-related adverse events induced by immune checkpoint inhibitors
by: Jonathan L Curry, et al.
Published: (2025-08-01)

Exploring molecular imaging to investigate immune checkpoint inhibitor-related toxicity
by: Rachel S van der Post, et al.
Published: (2025-05-01)

Pathogenesis, diagnosis and treatment of immune checkpoint inhibitor related bullous pemphigoid
by: Yi SUN, et al.
Published: (2025-04-01)

Research progress on treatment of pleural effusion related to immune checkpoint inhibitors
by: AN Tianqi, TIAN Jianhui, ZHOU Yiyang, LUO Bin, QUE Zujun, LIU Yao, YU Pan, ZHAO Ruihua, YANG Yun
Published: (2025-03-01)

Endoscopic findings of immune checkpoint inhibitor-related gastrointestinal adverse events
by: Min Kyu Kim, et al.
Published: (2024-11-01)

Clinical and pathological characteristics of immune checkpoint inhibitor-related fulminant myocarditis
by: Ryo Izumi, et al.
Published: (2024-11-01)

Neuroimaging features of immune-related adverse events due to immune checkpoint inhibitor therapy
by: Arian Lasocki, et al.
Published: (2025-06-01)

Establishment of an animal model of immune‐related adverse events induced by immune checkpoint inhibitors
by: Yuan Meng, et al.
Published: (2024-07-01)

Memories of our research on the hypothalamo-hypophyseal system
by: Kinji Inoue
Published: (2024-08-01)

Immune-Related Peripheral Neuropathy Associated with Immune Checkpoint Inhibitors: Case Report and Review of Literature
by: Carlos Eduardo Bonilla, et al.
Published: (2024-01-01)

Commentary: Immune-related intestinal pseudo-obstruction caused by immune checkpoint inhibitors: case report
by: Jie-Qiang Xia, et al.
Published: (2025-05-01)

Reporting of late-onset immune-related adverse events with immune checkpoint inhibitors in VigiBase
by: Alessandro Ceschi, et al.
Published: (2024-11-01)

Imaging features and prognostic significance of immune checkpoint inhibitor–related pneumonitis in NSCLC
by: Xueqi Wang, et al.
Published: (2025-07-01)

Open-capsule budesonide for the treatment of immune-related enteritis from checkpoint inhibitors
by: Amitabh Srivastava, et al.
Published: (2024-07-01)

Clinical characteristic analysis of immune checkpoint inhibitor-related pituitary adverse events
by: Yufan ZHENG, et al.
Published: (2025-08-01)

Enteritis of the ileal conduit as an adverse event related to immune checkpoint inhibitor use
by: Ko Kobayashi, et al.
Published: (2025-01-01)